Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...

A Boston-based neurotech, armed with up to $500,000 in Rhode Island incentives, plans to establish a location in Providence.

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Cuts to funding risk hobbling Boston’s science establishment ...

Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

That drug in question is efimosfermin, Boston Pharmaceuticals’ lead asset. The asset has already passed midstage tests and is now a phase 3-ready therapy to help stop the progression of ...

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Biotech stocks lagged the broader market ...

Business of Pride Join the Boston Business Journal for our 9th annual Business of Pride event! 2025 40 Under 40 They are among the most talented young professionals in Massachusetts. And they're ...

Boston’s own picks aren’t directly impacted at all by the outcome (the Celtics will pick at No. 28 overall in the first round). However, there are a number of intriguing implications involved ...

The partner of Theranos founder Elizabeth Holmes has raised millions of dollars for an artificial intelligence startup hoping to introduce a product that can be used in medical testing and other ...

The Business of Pride Business of Pride Annual Celebration and Awards Ceremony! Another big biotech pledges billions for U.S. manufacturing Another big biotech pledges billions for U.S ...

It’s huge news for the local dining scene: The Michelin Guide is coming to Boston. The guide, started by a French tire company more than a century ago, sends anonymous inspectors into the field ...